Neoadjuvant Nivolumab and Ipilimumab for Resectable Stage III Melanoma: The New Standard of Care?

被引：0
|
作者：
Miura, John T. [1 ]
Karakousis, Giorgos C. [1 ]
机构：
[1] Hosp Univ Penn, Div Endocrine & Oncol Surg, Philadelphia, PA 19104 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2025年 / 32卷 / 03期
关键词：
D O I：
10.1245/s10434-024-16807-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1394 / 1396
页数：3
相关论文
共 50 条
  • [1] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
    Blank, Christian U.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta
    Hoeijmakers, Lotte L.
    Saw, Robyn P. M.
    Lijnsvelt, Judith M.
    Maher, Nigel G.
    Pulleman, Saskia M.
    Gonzalez, Maria
    Torres Acosta, Alejandro
    van Houdt, Winan J.
    Lo, Serigne N.
    Kuijpers, Anke M. J.
    Spillane, Andrew
    Klop, W. Martin C.
    Pennington, Thomas E.
    Zuur, Charlotte L.
    Shannon, Kerwin F.
    Seinstra, Beatrijs A.
    Rawson, Robert V.
    Haanen, John B. A. G.
    Ch'ng, Sydney
    Naipal, Kishan A. T.
    Stretch, Jonathan
    van Thienen, Johannes V.
    Rtshiladze, Michael A.
    Wilgenhof, Sofie
    Kapoor, Rony
    Meerveld-Eggink, Aafke
    Grijpink-Ongering, Lindsay G.
    van Akkooi, Alexander C. J.
    Reijers, Irene L. M.
    Gyorki, David E.
    Gruenhagen, Dirk J.
    Speetjens, Frank M.
    Vliek, Sonja B.
    Placzke, Joanna
    Spain, Lavinia
    Stassen, Robert C.
    Amini-Adle, Mona
    Lebbe, Celeste
    Faries, Mark B.
    Robert, Caroline
    Ascierto, Paolo A.
    van Rijn, Rozemarijn
    van den Berkmortel, Franchette W. P. J.
    Piersma, Djura
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (18): : 1696 - 1708
  • [2] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
    Blank, Christian U.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta
    Hoeijmakers, Lotte L.
    Saw, Robyn P. M.
    Lijnsvelt, Judith M.
    Maher, Nigel G.
    Pulleman, Saskia M.
    Gonzalez, Maria
    Acosta, Alejandro Torres
    van Houdt, Winan J.
    Lo, Serigne N.
    Kuijpers, Anke M. J.
    Spillane, Andrew
    Klop, W. Martin C.
    Pennington, Thomas E.
    Zuur, Charlotte L.
    Shannon, Kerwin F.
    Seinstra, Beatrijs A.
    Rawson, Robert V.
    Haanen, John B. A. G.
    Ch'ng, Sydney
    Naipal, Kishan A. T.
    Stretch, Jonathan
    van Thienen, Johannes V.
    Rtshiladze, Michael A.
    Wilgenhof, Sofie
    Kapoor, Rony
    Meerveld-Eggink, Aafke
    Grijpink-Ongering, Lindsay G.
    van Akkooi, Alexander C. J.
    Reijers, Irene L. M.
    Gyorki, David E.
    Gruenhagen, Dirk J.
    Speetjens, Frank M.
    Vliek, Sonja B.
    Placzke, Joanna
    Spain, Lavinia
    Stassen, Robert C.
    Amini-Adle, Mona
    Lebbe, Celeste
    Faries, Mark B.
    Robert, Caroline
    Ascierto, Paolo A.
    van Rijn, Rozemarijn
    van den Berkmortel, Franchette W. P. J.
    Piersma, Djura
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [3] Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable stage III melanoma
    Lowe, M.
    Yushak, M. L.
    Olson, B.
    Mokhtari, A.
    Harutyunyan, A.
    Delman, K.
    Parker, D.
    Evans, E.
    Fisher, T.
    Lesinski, G.
    Kudchadkar, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S906 - S906
  • [4] Neoadjuvant Pepinemab in Combination with Nivolumab and/ or Ipilimumab in Resectable Stage III Melanoma
    Lowe, Michael C.
    Olson, Brian
    Yushak, Melinda
    Mallow, Crystal
    Reilly, Christine
    Hammons, Jacklyn
    Burns, Brian
    Mokhtari, Ali
    Parker, Doug
    Fisher, Terry
    Evans, Elizabeth
    Paulos, Chrystal
    Delman, Keith
    Lesinski, Gregory
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S5 - S5
  • [5] Neoadjuvant nivolumab versus combination ipilimumab and nivolumab followed by adjuvant nivolumab in patients with resectable stage III and oligometastatic stage IV melanoma: preliminary findings
    Reddy, Sangeetha M.
    Amaria, Rodabe N.
    Spencer, Christine N.
    Tetzlaff, Michael
    Reuben, Alexandre
    Andrews, Miles
    Wang, Linghua
    Woodman, Scott
    Zhu, Haifeng
    Blando, Jorge
    Vence, Luis
    Zhang, Shaojun
    Jiang, Hong
    Gopalakrishnan, Vancheswaran
    Hudgens, Courtney
    Wani, Khalida
    Tawbi, Hussein
    Diab, Adi
    Glitza, Isabella
    Patel, Sapna
    Hwu, Wen-Jen
    Wong, Michael
    Hwu, Patrick
    Cormier, Janice
    Lucci, Anthony
    Royal, Richard
    Lee, Jeffrey E.
    Simpson, Lauren
    Burton, Elizabeth M.
    Gershenwald, Jeffrey E.
    Ross, Merrick
    Allison, James
    Sharma, Padmanee
    Davies, Michael
    Wargo, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [6] Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta I.
    van Akkooi, Alexander Christopher Jonathan
    van Houdt, Winan J.
    Saw, Robyn P. M.
    Torres Acosta, Alex
    Lo, Serigne N.
    Hospers, Geke
    Carlino, Matteo S.
    de Groot, Jan Willem
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Rutkowski, Piotr
    Sandhu, Shahneen
    van der Veldt, Astrid Aplonia Maria
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL)
  • [7] Neoadjuvant therapy with ipilimumab and nivolumab for stage III malignant melanoma - a case report
    Hansen, I.
    Heidrich, I.
    Belz, S.
    Noebel, C.
    Geidel, G.
    Hildebrandt, L.
    Schneider, S. W.
    Gebhardt, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 87 - 88
  • [8] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Blank, Christian U.
    Rozeman, Elisa A.
    Fanchi, Lorenzo F.
    Sikorska, Karolina
    van de Wiel, Bart
    Kvistborg, Pia
    Krijgsman, Oscar
    van den Braber, Marlous
    Philips, Daisy
    Broeks, Annegien
    van Thienen, Johannes, V
    Mallo, Henk A.
    Adriaansz, Sandra
    ter Meulens, Sylvia
    Pronk, Loes M.
    Grijpink-Ongering, Lindsay G.
    Bruining, Annemarie
    Gittelman, Rachel M.
    Warren, Sarah
    van Tinteren, Harm
    Peeper, Daniel S.
    Haanen, John B. A. G.
    van Akkooi, Alexander C. J.
    Schumacher, Ton N.
    NATURE MEDICINE, 2018, 24 (11) : 1655 - +
  • [9] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Christian U. Blank
    Elisa A. Rozeman
    Lorenzo F. Fanchi
    Karolina Sikorska
    Bart van de Wiel
    Pia Kvistborg
    Oscar Krijgsman
    Marlous van den Braber
    Daisy Philips
    Annegien Broeks
    Johannes V. van Thienen
    Henk A. Mallo
    Sandra Adriaansz
    Sylvia ter Meulen
    Loes M. Pronk
    Lindsay G. Grijpink-Ongering
    Annemarie Bruining
    Rachel M. Gittelman
    Sarah Warren
    Harm van Tinteren
    Daniel S. Peeper
    John B. A. G. Haanen
    Alexander C. J. van Akkooi
    Ton N. Schumacher
    Nature Medicine, 2018, 24 : 1655 - 1661
  • [10] The NADINA trial: A multicenter, randomised, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma.
    Lucas, Minke W.
    Lijnsvelt, Judith
    Pulleman, Saskia
    Scolyer, Richard A.
    Menzies, Alexander M.
    Van Akkooi, Alexander Christopher Jonathan
    Van Houdt, Winan J.
    Shannon, Kerwin Frank
    Pennington, Thomas
    Suijkerbuijk, Karijn
    Kapiteijn, Ellen
    Van der Veldt, Astrid Aplonia Maria
    Carlino, Matteo S.
    Sandhu, Shahneen
    Gonzalez, Maria
    Klop, Charlotte L. Zuur W. Martin. C.
    Long, Georgina V.
    Blank, Christian U.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345